SFSilvaneide Ferreira

Silvaneide Ferreira

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Silvaneide Ferreira has a total of 26 co-authors. Here are the top co-authors by number of shared publications:

  • Lara Termini

    Laboratório de Inovação em Câncer, Centro de Pesquisa Translacional em Oncologia (CTO), Instituto do Câncer do Estado de São Paulo (ICESP), Faculdade de Medicina, Universidade de São Paulo, São Paulo 01246-000, Brazil

    2 shared publications
  • Laura Sichero

    Center for Translational Research in Oncology, Instituto do Cancer do Estado de Sao Paulo-ICESP, Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo-FMUSP HC, Sao Paulo, Brazil; Comprehensive Center for Precision Oncology-C2PO, Universidade de Sao Paulo-FMUSP HC, Sao Paulo, Brazil

    2 shared publications
  • Antonio José Gonçalves

    Head & Neck Surgery Discipline, Surgery Department, Irmandade da Santa Casa de Misericórdia de São Paulo, São Paulo, Brazil

    1 shared publication
  • Claudio Roberto Cernea

    Department of Head and Neck Surgery, University of São Paulo Medical School, São Paulo, Brazil

    1 shared publication
  • Clemente Isnard Ribeiro de Almeida

    Department of Otolaringology, Santa Casa de Sao Paulo, School of Medicine (FCMSCSP), São Paulo, Brazil

    1 shared publication
  • Emily Montosa Nunes

    Molecular Biology Laboratory, Center for Translational Research in Oncology, Instituto do Câncer do Estado de São Paulo - ICESP, São Paulo, Brazil

    1 shared publication

Latest Publications

  • Open Access

    E6/E7 Functional Differences among Two Natural Human Papillomavirus 18 Variants in Human Keratinocytes

    by Emily Montosa Nunes, Valéria Talpe-Nunes, João Simão Sobrinho, Silvaneide Ferreira, Vanesca de Souza Lino, Lara Termini, Gabriela Ávila Fernandes Silva, Enrique Boccardo, Luisa Lina Villa, Laura Sichero

    It is suggested that HPV-18 variants from the A lineage have higher oncogenic potential compared to B variants. Some studies show uneven distribution of HPV-18 variants in cervical adenocarcinomas and squamous cell carcinomas. Regarding HPV-18 variants’ functions, the few studies reported focus on E6, and none were performed using natural host cells. Here, we immortalized primary human keratinocytes (PHKs) with E6/E7 of HPV-18 A1 and B1 sublineages and functionally characterized these cells. PHK18A1 reached immortalization significantly faster than PHK18B1 and formed a higher number of colonies in monolayer and 3D cultures. Moreover, PHK18A1 showed greater invasion ability and higher resistance to apoptosis induced by actinomycin-D. Nevertheless, no differences were observed regarding morphology, proliferation after immortalization, migration, or epithelial development in raft cultures. Noteworthy, our study highlights qualitative differences among HPV-18 A1 and B1 immortalized PHKs: in contrast to PHK18A1, which formed more compact colonies and spheroids of firmly grouped cells and tended to invade and migrate as clustered cells, morphologically, PHK18B1 colonies and spheroids were looser, and migration and invasion of single cells were observed. Although these observations may be relevant for the association of these variants with cervical cancer of different histological subtypes, further studies are warranted to elucidate the mechanisms behind these findings.


  • Open Access

    Prevalence of human papillomavirus types and variants and p16INK4a expression in head and neck squamous cells carcinomas in São Paulo, Brazil

    by Julio C. Betiol, Laura Sichero, Henrique O. de Olival Costa, Leandro L. de Matos, Maria A. Andreoli, Silvaneide Ferreira, Sheila F. Faraj, Evandro S. de Mello, João S. Sobrinho, Lenine G. Brandão, et al.

    Human papillomavirus (HPV) prevalence in head and neck squamous cell carcinomas (HNSCC) diverges geographically. The reliability of using p16INK4a expression as a marker of viral infection is controversial in HNSCC. We evaluated HPV types and HPV-16 variants prevalence, and p16INK4a expression in HNSCC specimens provided by two different Institutions in São Paulo. HPV DNA from formalin-fixed specimens was accessed by Inno-LiPA, HPV-16 variants by PCR-sequencing, and p16INK4a protein levels by immunohistochemistry. Overall, HPV DNA was detected among 19.4 % of the specimens (36/186). Viral prevalence was higher in the oral cavity (25.0 %, 23/92) then in other anatomical sites (oropharynx 14,3 %, larynx 13.7 %) when samples from both Institutions were analyzed together. HPV prevalence was also higher in the oral cavity when samples from both Institutions were analyzed separately. HPV-16 was the most prevalent type identified in 69.5 % of the HPV positive smaples and specimens were assigned into Asian-American (57.2 %) or European (42.8 %) phylogenetic branches. High expression of p16INK4a was more common among HPV positive tumors. Our results support a role for HPV-16 in a subset of HNSCC.